REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN)

1,127 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q3 2021.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 991 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 69.5M shares of 105M outstanding shares and own 66.19% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8.07M shares), Capital World Investors (5.32M shares), STATE STREET CORP (4.64M shares), JPMORGAN CHASE & CO (4.1M shares), WELLINGTON MANAGEMENT GROUP LLP (3.37M shares), LOOMIS SAYLES & CO L P (2.76M shares), GEODE CAPITAL MANAGEMENT, LLC (1.74M shares), PUTNAM INVESTMENTS LLC (1.34M shares), HARRIS ASSOCIATES L P (1.33M shares), and NORTHERN TRUST CORP (1.2M shares).
This table shows the top 991 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.